Dopamine D₄ Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy

Area of Science:

• Neuroscience
• Pharmacology
• Medicinal Chemistry

Background:

• The dopamine D4 receptor (D4R) is implicated in cognitive functions, attention, and decision-making processes.
• Selective D4R ligands are sought for treating neuropsychiatric conditions such as Alzheimer's disease and substance use disorders.

Purpose of the Study:

• To identify novel D4R-selective ligands.
• To elucidate molecular mechanisms governing agonist efficacy at the D4R.

Main Methods:

• Synthesis of eighteen novel ligands based on the D4R agonist A-412997.
• Radioligand binding displacement assays.
• Beta-arrestin recruitment assays.
• Cyclic AMP inhibition assays.
• Molecular dynamics computational modeling.

Main Results:

• Identification of several novel D4R-selective compounds (Ki ≤ 4.3 nM, >100-fold selectivity over other D2-like receptors).
• Compounds exhibited diverse partial agonist and antagonist profiles, categorized into three structural groups.
• Characterization of receptor-ligand interactions influencing efficacy at D2-like receptors.

Conclusions:

• The novel ligands provide valuable tools for D4R research.
• Findings may advance targeted drug discovery for neuropsychiatric disorders.
• Enhanced understanding of D4R's role in neurological conditions.